Eisai Co., Ltd. (4523.T)
JPY 4338.0
(-0.28%)
JPY 4338.0
(-0.28%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 206.74 Billion JPY | 63.95% |
| 2022 | 126.1 Billion JPY | 32.89% |
| 2021 | 94.89 Billion JPY | 5.56% |
| 2020 | 89.89 Billion JPY | -0.05% |
| 2019 | 89.93 Billion JPY | -35.25% |
| 2018 | 138.89 Billion JPY | -19.78% |
| 2017 | 173.14 Billion JPY | -18.89% |
| 2016 | 213.47 Billion JPY | 4.85% |
| 2015 | 203.59 Billion JPY | -13.76% |
| 2014 | 236.08 Billion JPY | -4.56% |
| 2013 | 247.37 Billion JPY | -21.23% |
| 2012 | 314.02 Billion JPY | -9.06% |
| 2011 | 345.3 Billion JPY | -9.1% |
| 2010 | 379.88 Billion JPY | -7.3% |
| 2009 | 409.81 Billion JPY | -2.82% |
| 2008 | 421.7 Billion JPY | 1.95% |
| 2007 | 413.64 Billion JPY | 175175.0% |
| 2006 | 236 Million JPY | -42.86% |
| 2005 | 413 Million JPY | -50.48% |
| 2004 | 834 Million JPY | 336.65% |
| 2003 | 191 Million JPY | 41.48% |
| 2002 | 135 Million JPY | -87.19% |
| 2001 | 1.05 Billion JPY | -94.26% |
| 2000 | 18.37 Billion JPY | 2.33% |
| 1999 | 17.95 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 182.33 Billion JPY | -11.81% |
| 2023 Q4 | 206.74 Billion JPY | 24.35% |
| 2023 Q1 | 136.21 Billion JPY | 8.02% |
| 2023 FY | 206.74 Billion JPY | 63.95% |
| 2023 Q2 | 133.22 Billion JPY | -2.19% |
| 2023 Q3 | 166.26 Billion JPY | 24.79% |
| 2022 Q2 | 94.91 Billion JPY | 0.01% |
| 2022 FY | 126.1 Billion JPY | 32.89% |
| 2022 Q3 | 150.12 Billion JPY | 58.17% |
| 2022 Q4 | 126.1 Billion JPY | -16.0% |
| 2022 Q1 | 94.9 Billion JPY | 0.01% |
| 2021 Q3 | 89.92 Billion JPY | 0.01% |
| 2021 FY | 94.89 Billion JPY | 5.56% |
| 2021 Q1 | 92.68 Billion JPY | 3.1% |
| 2021 Q4 | 94.89 Billion JPY | 5.53% |
| 2021 Q2 | 89.91 Billion JPY | -2.99% |
| 2020 Q3 | 89.88 Billion JPY | 0.01% |
| 2020 Q2 | 89.87 Billion JPY | -0.08% |
| 2020 FY | 89.89 Billion JPY | -0.05% |
| 2020 Q1 | 89.94 Billion JPY | 0.01% |
| 2020 Q4 | 89.89 Billion JPY | 0.01% |
| 2019 Q1 | 129.91 Billion JPY | -6.47% |
| 2019 Q2 | 115.42 Billion JPY | -11.15% |
| 2019 Q3 | 113.93 Billion JPY | -1.29% |
| 2019 Q4 | 89.93 Billion JPY | -21.06% |
| 2019 FY | 89.93 Billion JPY | -35.25% |
| 2018 Q2 | 163.94 Billion JPY | -14.62% |
| 2018 Q1 | 192.02 Billion JPY | 10.9% |
| 2018 Q3 | 129.88 Billion JPY | -20.77% |
| 2018 FY | 138.89 Billion JPY | -19.78% |
| 2018 Q4 | 138.89 Billion JPY | 6.94% |
| 2017 Q2 | 220.16 Billion JPY | -2.07% |
| 2017 Q4 | 173.14 Billion JPY | -24.12% |
| 2017 FY | 173.14 Billion JPY | -18.89% |
| 2017 Q1 | 224.8 Billion JPY | 5.31% |
| 2017 Q3 | 228.17 Billion JPY | 3.64% |
| 2016 Q1 | 210.65 Billion JPY | 3.47% |
| 2016 FY | 213.47 Billion JPY | 4.85% |
| 2016 Q4 | 213.47 Billion JPY | -0.6% |
| 2016 Q3 | 214.75 Billion JPY | 2.2% |
| 2016 Q2 | 210.12 Billion JPY | -0.25% |
| 2015 FY | 203.59 Billion JPY | -13.76% |
| 2015 Q1 | 217.04 Billion JPY | -8.06% |
| 2015 Q2 | 216.3 Billion JPY | -0.34% |
| 2015 Q3 | 227.04 Billion JPY | 4.96% |
| 2015 Q4 | 203.59 Billion JPY | -10.33% |
| 2014 Q4 | 236.08 Billion JPY | -10.3% |
| 2014 Q2 | 240.31 Billion JPY | -0.28% |
| 2014 Q1 | 240.97 Billion JPY | -2.58% |
| 2014 Q3 | 263.17 Billion JPY | 9.52% |
| 2014 FY | 236.08 Billion JPY | -4.56% |
| 2013 Q1 | 257.53 Billion JPY | -17.99% |
| 2013 FY | 247.37 Billion JPY | -21.23% |
| 2013 Q2 | 251.76 Billion JPY | -2.24% |
| 2013 Q3 | 267.36 Billion JPY | 6.2% |
| 2013 Q4 | 247.37 Billion JPY | -7.48% |
| 2012 FY | 314.02 Billion JPY | -9.06% |
| 2012 Q1 | 346.08 Billion JPY | 0.22% |
| 2012 Q4 | 314.02 Billion JPY | -4.99% |
| 2012 Q3 | 330.5 Billion JPY | 9.22% |
| 2012 Q2 | 302.6 Billion JPY | -12.56% |
| 2011 FY | 345.3 Billion JPY | -9.1% |
| 2011 Q3 | 363.63 Billion JPY | 8.23% |
| 2011 Q1 | 338.43 Billion JPY | -10.91% |
| 2011 Q4 | 345.3 Billion JPY | -5.04% |
| 2011 Q2 | 335.98 Billion JPY | -0.72% |
| 2010 Q1 | 399.07 Billion JPY | -2.62% |
| 2010 FY | 379.88 Billion JPY | -7.3% |
| 2010 Q4 | 379.88 Billion JPY | -1.81% |
| 2010 Q2 | 384.28 Billion JPY | -3.71% |
| 2010 Q3 | 386.88 Billion JPY | 0.68% |
| 2009 Q2 | 421.01 Billion JPY | -1.66% |
| 2009 Q4 | 409.81 Billion JPY | -7.59% |
| 2009 FY | 409.81 Billion JPY | -2.82% |
| 2009 Q3 | 443.45 Billion JPY | 5.33% |
| 2009 Q1 | 428.12 Billion JPY | 1.52% |
| 2008 Q4 | 421.7 Billion JPY | 0.0% |
| 2008 FY | 421.7 Billion JPY | 1.95% |
| 2007 FY | 413.64 Billion JPY | 175175.0% |
| 2006 FY | 236 Million JPY | -42.86% |
| 2005 FY | 413 Million JPY | -50.48% |
| 2004 FY | 834 Million JPY | 336.65% |
| 2003 FY | 191 Million JPY | 41.48% |
| 2002 FY | 135 Million JPY | -87.19% |
| 2001 FY | 1.05 Billion JPY | -94.26% |
| 2000 FY | 18.37 Billion JPY | 2.33% |
| 1999 FY | 17.95 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -1124.001% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 95.732% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 50.644% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -1679.225% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -205558.069% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -7098.677% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -5270.026% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -48546.118% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -9745.048% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -55928.726% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -1525.106% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -1117.514% |
| Tsumura & Co. | 79.69 Billion JPY | -159.438% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -11871.395% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -84631.967% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | -2.169% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -614.198% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | -334.469% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | -887.043% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -5327.829% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -2271.212% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -344476.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -50020.242% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -2079.715% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | -149.422% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -22544.688% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | -583.593% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -7217.696% |